跳至主要内容
临床试验/ITMCTR2200005576
ITMCTR2200005576尚未招募未知

Real world clinical research and development application of Roogan Tongluo Granule (renamed Sangdan Tongluo granule) in the treatment of ischemic stroke

Affiliated Hospital of Hunan Academy of Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational study

入排标准

年龄范围
18 至 75(—)
性别
All

入选标准

  • ? Western diagnosis conforms to the diagnostic criteria of ischemic stroke;? TCM diagnosis belongs to apoplexy;? The duration of the disease is between 2 weeks and 6 months;? Good compliance, aged between 18 and 75 years old;(5) with limb dysfunction, and not accompanied by other diseases affecting neurological function and life ability evaluation;? Patients or their family members agree and sign informed consent.

排除标准

  • ? The course of treatment is less than 1 month;? The medical records are not complete, and the return visit cannot be obtained.

研究者

发起方
Affiliated Hospital of Hunan Academy of Chinese Medicine

相似试验